Latest Breaking News On - Global medical affairs - Page 28 : comparemela.com

Ascelia Pharma presented Orviglance Hepatic Impairment Data and hosted a Q&A with liver imaging experts at the 2023 ESGAR Annual Meeting

BioPharma

United statesAscelia pharmaNikolaos kartalisAlessandro furlanNadilka hettiarachchigeTexas liver instituteEuropean society of gastrointestinalDepartment of radiology huddingeGlobal medical affairs at ascelia pharmaDrug administrationKarolinska university hospitalHepatic impairment studyEuropean societyAbdominal radiologyAnnual meetingOrphan drug designation

Drug-resistant Candida auris infection rates continue to rise

Drug-resistant Candida auris infection rates continue to rise
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesTristant timbookAmerican society for microbiologyGlobal medical affairsHealth economics outcomes researchCenters for diseaseAmerican societyDisease controlDrug resistant candida

Researchers find an upsurge in antimicrobial-resistant C auris infections

Candida auris, an emerging fungal pathogen resistant to many antimicrobial agents, continues to threaten U.S. public health.

United statesTristant timbookKristenl jurcic smithBenw galvinDanielle ellisTristant timbrookJayd jonesGlobal medical affairsCenters for diseaseHealth economics outcomes researchAmerican society for microbiologyAmerican societyDisease controlPresenting authorBrooklyn noble

Rising Infection Rates of Drug-Resistant Candida Auris

Rising Infection Rates of Drug-Resistant Candida Auris
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesJayd jonesKristenl jurcic smithBenw galvinTristant timbrookTristant timbookHealth economics outcomes researchAmerican society for microbiologyCenters for diseaseGlobal medical affairsAmerican societyDisease controlBrooklyn noble

Ipsen to present new data on clinical outcomes and patient validation tools from growing rare liver disease portfolio at EASL 2023

Seven abstracts to be presented demonstrating treatment effects of Bylvay® in two cholestatic liver diseases, progressive familial intrahepatic cholestasis and Alagille syndrome Data to be. | June 12, 2023

France generalUnited statesUnited kingdomSan sebastianPais vascoMarwan sleimanFranciscoj caballero caminoHenkjan verkadeAmy wolfAsia pacificBettina hansenPeter serafiniAhmed ghallabEkkehard sturmIpsen euronextIoana piscociu